Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
4565 On Other Exchanges
4565 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peter James Jonathan Bains

External Director, Member of Audit Committee and Member of Compensation Committee,Sosei Group Corporation
AgeTotal Calculated CompensationThis person is connected to 53 board members in 8 different organizations across 8 different industries.

See Board Relationships


Mr. Peter James Jonathan Bains has been the Chief Executive Officer of Syngene International Ltd. since February 2, 2015. Mr. Bains serves as a Senior Advisor of Phase4 Partners Limited. Mr. Bains has been a Consultant specializing in supporting strategic growth opportunities in small- and medium-sized innovation-based life science companies since 2009. He has more than two decades of experience in the global pharmaceutical space encompassing strategic and operational ...

Read Full Background

Corporate Headquarters*

Kojimachi Tsuruya Hachiman Building
Tokyo, -- 102-0083


Phone: 81 3 5210 3290
Fax: 81 3 5210 3291

Board Members Memberships*

Senior Advisor and Non-Executive Director
External Director, Member of Audit Committee and Member of Compensation Committee
Chief Executive Officer and Director
Non Executive Chairman, Chairman of Corporate Social Responsibility (CSR) Committee and Member of Audit Committee
Non-Executive Director and Member of Audit Committee


The University of Sheffield

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4565:JP ¥5,530.00 JPY -40.00


Steven M. Klosk Chief Executive Officer, President and Director
Cambrex Corporation.
Timothy J. Miller Ph.D.Chief Executive Officer, President and Director
Abeona Therapeutics Inc.
Stephen Edward Foots Group Chief Executive, Executive Director, Chairman of Group Executive Committee, Member of Nomination Committee, Member of Routine Business Committee, Member of Group Safety, Health & Environment Steering Committee, Member of Finance Committee and Member of Risk Management Committee
Croda International plc
600.0K GBP
Narayanan Govindarajan Managing Director, Director and Member of Risk Management Committee
Aurobindo Pharma Limited
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SOSEI GROUP CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at